| Literature DB >> 20107217 |
Niraj C Patel1, Paula M Hertel, Mary K Estes, Maite de la Morena, Ann M Petru, Lenora M Noroski, Paula A Revell, I Celine Hanson, Mary E Paul, Howard M Rosenblatt, Stuart L Abramson.
Abstract
Live pentavalent human-bovine reassortant rotavirus vaccine is recommended in the United States for routine immunization of infants. We describe three infants, two with failure to thrive, who had dehydration and diarrhea within 1 month after their first or second rotavirus immunization and subsequently received a diagnosis of severe combined immunodeficiency. Rotavirus was detected, by means of reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assay, in stool specimens obtained from all three infants, and gene-sequence analysis revealed the presence of vaccine rotavirus. These infections raise concerns regarding the safety of rotavirus vaccine in severely immunocompromised patients. 2010 Massachusetts Medical SocietyEntities:
Mesh:
Substances:
Year: 2010 PMID: 20107217 PMCID: PMC4103739 DOI: 10.1056/NEJMoa0904485
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245